Difference between revisions of "Part:BBa K3096015"
| Line 2: | Line 2: | ||
pVEC (peptide vascular endothelial-cadherin) is a cell penetrating peptide, which transports proteins through coadministration. | pVEC (peptide vascular endothelial-cadherin) is a cell penetrating peptide, which transports proteins through coadministration. | ||
| − | |||
| − | |||
| − | |||
===Sequence and Features=== | ===Sequence and Features=== | ||
| Line 14: | Line 11: | ||
<!-- Uncomment this to enable Functional Parameter display | <!-- Uncomment this to enable Functional Parameter display | ||
| + | |||
| + | <!--===Usage and Biology=== | ||
| + | --!> | ||
| + | |||
===Functional Parameters=== | ===Functional Parameters=== | ||
<partinfo>BBa_K3096015 parameters</partinfo> | <partinfo>BBa_K3096015 parameters</partinfo> | ||
<!-- --> | <!-- --> | ||
Revision as of 14:00, 15 October 2019
pVEC - a cell penetrating peptide
pVEC (peptide vascular endothelial-cadherin) is a cell penetrating peptide, which transports proteins through coadministration.
Sequence and Features
Assembly Compatibility:
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000COMPATIBLE WITH RFC[1000]
References
- Kamei, Noriyasu, et al. "Usefulness of cell-penetrating peptides to improve intestinal insulin absorption." Journal of Controlled Release 132.1 (2008): 21-25.